Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HDHD2 | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-10 |
mRNA | MYT1 | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-10 |
mRNA | DUSP26 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
mRNA | KIF1A | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-10 |
mRNA | CRTC1 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-10 |
mRNA | ZNF22 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-09 |
mRNA | MARCKSL1 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | LRRC37B | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | CIC | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | TXNDC16 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |